Home Tools
Log in
Cart

BMS-345541

Catalog No. T6326   CAS 445430-58-0
Synonyms: BMS-345541 free base, IKK Inhibitor III, BMS345541

BMS-345541 (IKK Inhibitor III) is a highly selective inhibitor of the catalytic subunits of IKK-2 and IKK-1 with IC50 of 0.3 μM and 4 μM, respectively.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.
BMS-345541 Chemical Structure
BMS-345541, CAS 445430-58-0
Pack Size Availability Price/USD Quantity
1 mg In stock $ 32.00
2 mg In stock $ 45.00
5 mg In stock $ 72.00
10 mg In stock $ 113.00
25 mg In stock $ 228.00
50 mg In stock $ 372.00
100 mg In stock $ 548.00
200 mg In stock $ 783.00
1 mL * 10 mM (in DMSO) In stock $ 94.00
Bulk Inquiry
Get quote
Select Batch  
Purity: 99.29%
Contact us for more batch information
Biological Description
Chemical Properties
Storage & Solubility Information
Description BMS-345541 (IKK Inhibitor III) is a highly selective inhibitor of the catalytic subunits of IKK-2 and IKK-1 with IC50 of 0.3 μM and 4 μM, respectively.
Targets&IC50 IKK2:0.3 μM, IKK1:4 μM
In vitro Tumor-bearing mice treated with 75 mg/kg of BMS-345541 exhibited effective growth inhibition against SK-MEL-5, A375, and Hs 294T, with inhibition rates of 86%, 69%, and 67%, respectively, compared to the control group. At a dosage of 100 mg/kg, BMS-345541 reduced cumulative arthritis damage scores from 4.4 to 0, accompanied by lower degrees of tibial joint degeneration, severity of inflammation, synovial proliferation, bone absorption, and cartilage erosion. BMS-345541 dose-dependently inhibited IL-1β signaling, with animals in the 100 mg/kg dosage group displaying levels comparable to disease-free control animals. Oral administration of 100 mg/kg BMS-345541 reduced the weight ratio, clinical intestinal scores, average damage scores, and average inflammation scores in mice induced with dextran sulfate sodium colitis, which were 0.86 (vs the control group’s 0.77), 1.0 (vs the control group’s 2.5), 5.66 (vs the control group’s 8.52), and 6.82 (vs the control group’s 12.33), respectively.
In vivo Treatment with 5 μM BMS-345541 induced cell cycle arrest at the G2/M phase in BE-13 and DND-41 cells and hindered RPMI-8402 cells from staying in the sub-G1 phase. This concentration, after 16 hours, led to an increase in apoptotic cells, along with time-dependent cleavage of procaspase-8, procaspase-3, and poly(ADP-ribose). Furthermore, 5 μM BMS-345541 triggered time-dependent dephosphorylation of IκBα and p65. At a concentration of 10 μM, BMS-345541 inhibited the growth of normal human epidermal melanocytes and metastatic melanoma cells (SK-MEL-5, A375, and HS294T), with inhibition rates of 96% and 99% after 72 hours, respectively. This dosage also reduced IKK activity by 76%, NF-kB activity by 95%, and diminished CXCL1 production. Dose-dependently, BMS-345541 inhibited the phosphorylation of IκBα stimulated by TNF-α in THP-1 monocytes, with an IC50 of 4 μM. In human umbilical vein endothelial cells, it suppressed the expression of TNFα-induced ICAM-1 and VCAM-1, with an IC50 of 5 μM. BMS-345541 binds to the allosteric sites of IKK-1 and IKK-2, affecting the activity sites of different subunits. It impacted various mitotic cell cycle transitions, including entry into mitosis, progression from early to late stages, and cytokinesis. Adding BMS-345541 to cells resulted in arrest at the G phase and inhibited the activation of Aurora A, B, and C, Cdk1, and the phosphorylation of histone H3. Treatment with BMS-34554 led to nuclear translocation of FOXO3a in T-ALL cells, including the regulation of p21 CIP1 gene expression levels. BMS-345541 also inhibited the growth of primary T-ALL cells from pediatric patients, with an IC50 of 2-6 μM.
Kinase Assay Enzyme Assays: Assays measuring the enzyme-catalyzed phosphorylation of GST-IκBα are performed by adding enzyme (a final concentration of 0.5 μg/mL) at 30 ℃ to solutions of 100 μg/mL GST- IκBα and 5 μM [33P]ATP in 40 mM Tris HCl, pH 7.5, containing 4 mM MgCl2, 34 mM sodium phosphate, 3 mM NaCl, 0.6 mM potassium phosphate, 1 mM KCl, 1 mM dithiothreitol, 3% (w/v) glycerol, and 250 μg/mL bovine serum albumin. The specific activity of [33P]ATP used in the assay is 100 Ci/mmol. After 5 min, the kinase reactions are stopped by the addition of 2× Laemmli sample buffer and heat-treated at 90 ℃ for 1 min. The samples are then loaded on to NuPAGE 10% BisTris gels. After completion of SDS-PAGE, gels are dried on a slab gel dryer. The bands are then detected using a 445Si PhosphorImager, and the radioactivity is quantified using ImageQuant software. Under these conditions, the degree of phosphorylation of GST-IκBα is linear with time and concentration of enzyme.
Cell Research 1×105 cells per well are plated in six-well plates with 10% fetal bovine serum medium overnight to allow cell adhesion. Cells ae cultured in medium containing BMS-345541 for 72 hours of treatment. Cells are counted with a hemocytometer.(Only for Reference)
Synonyms BMS-345541 free base, IKK Inhibitor III, BMS345541
Molecular Weight 255.32
Formula C14H17N5
CAS No. 445430-58-0

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

Solubility Information

DMSO: 9 mg/mL (35.24 mM)

Ethanol: < 1 mg/mL (insoluble or slightly soluble)

H2O: < 1 mg/mL (insoluble or slightly soluble)

TargetMolReferences and Literature

1. Burke JR, et al. J Biol Chem, 2003, 278(3), 1450-1456. 2. Blazkova H, et al. Cell Cycle, 2007, 6(20), 2531-2540. 3. Yang J, et al. Clin Cancer Res, 2006, 12(3 Pt 1), 950-960. 4. Buontempo F, et al. Cell Cycle, 2012, 11(13), 2467-2475. 5. MacMaster JF, et al. Inflamm Res, 2003, 52(12), 508-511.

TargetMolCitations

1. Chen J, Liu G, Wang X, et al. Glioblastoma stem cell-specific histamine secretion drives pro-angiogenic tumor microenvironment remodeling. Cell Stem Cell. 2022

Related compound libraries

This product is contained In the following compound libraries:
Highly Selective Inhibitor Library Inhibitor Library Kinase Inhibitor Library NO PAINS Compound Library Bioactive Compound Library Bioactive Compounds Library Max Pyroptosis Compound Library Anti-Breast Cancer Compound Library Anti-Prostate Cancer Compound Library Anti-Liver Cancer Compound Library

Related Products

Related compounds with same targets
LY2409881 trihydrochloride Cudraflavone B Protosappanin A AZD3264 Bay 11-7085 Rosmarinic acid BOT-64 TBK1/IKKε-IN-2

TargetMolDose Conversion

You can also refer to dose conversion for different animals. More

TargetMol In vivo Formulation Calculator (Clear solution)

Step One: Enter information below
Dosage
mg/kg
Average weight of animals
g
Dosing volume per animal
ul
Number of animals
Step Two: Enter the in vivo formulation
% DMSO
%
% Tween 80
% ddH2O
Calculate Reset

TargetMolCalculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculation
Molecular Weight Calculator
=
X
X

Molarity Calculator allows you to calculate the

  • Mass of a compound required to prepare a solution of known volume and concentration
  • Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Concentration of a solution resulting from a known mass of compound in a specific volume
See Example

An example of a molarity calculation using the molarity calculator
What is the mass of compound required to make a 10 mM stock solution in 10 ml of water given that the molecular weight of the compound is 197.13 g/mol?
Enter 197.13 into the Molecular Weight (MW) box
Enter 10 into the Concentration box and select the correct unit (millimolar)
Enter 10 into the Volume box and select the correct unit (milliliter)
Press calculate
The answer of 19.713 mg appears in the Mass box

X
=
X

Calculator the dilution required to prepare a stock solution

Calculate the dilution required to prepare a stock solution
The dilution calculator is a useful tool which allows you to calculate how to dilute a stock solution of known concentration. Enter C1, C2 & V2 to calculate V1.

See Example

An example of a dilution calculation using the Tocris dilution calculator
What volume of a given 10 mM stock solution is required to make 20ml of a 50 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=50 μM, V2=20 ml and V1 is the unknown:
Enter 10 into the Concentration (start) box and select the correct unit (millimolar)
Enter 50 into the Concentration (final) box and select the correct unit (micromolar)
Enter 20 into the Volume (final) box and select the correct unit (milliliter)
Press calculate
The answer of 100 microliter (0.1 ml) appears in the Volume (start) box

=
/

Calculate the volume of solvent required to reconstitute your vial.

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial.
Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

g/mol

Enter the chemical formula of a compound to calculate its molar mass and elemental composition

Tip: Chemical formula is case sensitive: C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed n the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

bottom

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.

Keywords

BMS-345541 445430-58-0 NF-Κb IκB/IKK BMS-345541 free base BMS 345541 Inhibitor inhibit IKK Inhibitor III BMS345541 IκB kinase IKK I kappa B kinase inhibitor

 

TargetMol